FAST NEWS: Henlius swings to the black on strong sales growth

2696.HK
Shanghai Henlius Biotech on Wednesday reported a net profit of 408 million yuan in the first three quarters of this year, reversing a loss of 343 million yuan in the same period last year.

The latest: Shanghai Henlius Biotech Inc. (2696.HK) on Wednesday reported a net profit of 408 million yuan ($56.2 million) in the first three quarters of this year, reversing a loss of 343 million yuan in the same period last year.

Looking up: Sales of the company’s two core products, Hanquyou and Hansizhuang, surged 52% and 321%, respectively, in China, fueling an 84% operating revenue increase to 3.93 billion yuan.

Take Note: The company’s cost of sales jumped 119% to 1.13 billion yuan due to higher spending on R&D and its greater sales volume during the period.

Digging Deeper: Founded in 2010, Henlius is a biopharmaceutical company owned by Fosun Pharma (2196.HK; 600196.SH), one of China’s leading private drug makers. The company debuted on the Hong Kong Stock Exchange in 2019 and made a major breakthrough the same year when it attained approval for rituximab, China’s first biosimilar for the treatment of Non-Hodgkin lymphoma and chronic lymphocytic leukemia. The company has commercialized five products for 18 approved indications, fueling strong sales growth that helped it achieve its first-ever profit in the first half of this year.

Market Reaction: Henlius shares rose on Thursday, closing up 3.6% at HK$14.96 by the midday break. It currently trades near the upper end of its 52-week range.

Translation by A. Au

Have a great investment idea but don’t know how to spread the word? We can help! Contact us for more details.

To subscribe to Bamboo Works weekly free newsletter, click here

,
, , , ,

Related Articles

RELATED ARTICLES

  1. Henlius Bio
    After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
    2696.HK
  2. Fosun moves on from debt crisis with renewed focus on tourism, healthcare
    0656.HK
  3. Baozun returns to the black as Gap expansion accelerates
    9991.HK BZUN.US
  4. Black Sesame emerges as dark horse in driving technology race
    2533.HK
  5. Its knuckles rapped, recovering Gaotu springs back to the black
    GOTU.US
  6. Yan Palace flies back to profit growth as revenue sags
    1497.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

Recent Articles

Illustration of a slot machine in a Macau casino

Macao’s end of an era, and a ghost ship in search of a business

An era has ended in Macao with the planned closure of the city's remaining "satellite casinos" by the end of the year. Does this represent the latest step in the corporatization of Macao? And former financier-turned-educator-turned -food seller Qudian has announced it's pulling out of its latest foray into last-mile delivery. What value for investors is there in this kind of ever-changing company?
QD.US